Shopping Cart 0
Cart Subtotal
AED 0

Global Oncology/Cancer Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Medical oncologists specialise in cancer treatment using drugs such as chemotherapy agents.

Scope of the Report:

This report focuses on the Oncology/Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

USFDA and European Union have undertaken significant initiatives to fuel the growth of global oncology/cancer drugs market by providing pre-market approval for potential drugs under clinical development.

Asia-Pacific and LAMEA are promising regions for conducting clinical trials due a large population base and the low cost of clinical trials as compared to North America and Europe

Japan has largest share to the total Asia Pacific cancer drug market due to the high prevalence of cancer in Japanese population. Lung cancer is the major cause of death in Japanese population.

The worldwide market for Oncology/Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Amgen

Johnson & Johnson

GlaxoSmithKline

Eli lilly

Roche diagnostics

Novartis

Pfizer

Merck

Sanofi

Celgene

Roche

Novartis

Celgene

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory/Lung Cancer

Skin Cancer

Other Cancers

Market Segment by Applications, can be divided into

Hospital

Clinic

Pharmacy

There are 15 Chapters to deeply display the global Oncology/Cancer Drugs market.

Chapter 1, to describe Oncology/Cancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oncology/Cancer Drugs, with sales, revenue, and price of Oncology/Cancer Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncology/Cancer Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oncology/Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oncology/Cancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Oncology/Cancer Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Blood Cancer

1.2.2 Breast Cancer

1.2.3 Gastrointestinal Cancer

1.2.4 Prostate Cancer

1.2.5 Respiratory/Lung Cancer

1.2.6 Skin Cancer

1.2.7 Other Cancers

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.3.3 Pharmacy

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Oncology/Cancer Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Johnson & Johnson

2.2.1 Business Overview

2.2.2 Oncology/Cancer Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Johnson & Johnson Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 Oncology/Cancer Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Eli lilly

2.4.1 Business Overview

2.4.2 Oncology/Cancer Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eli lilly Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Roche diagnostics

2.5.1 Business Overview

2.5.2 Oncology/Cancer Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Roche diagnostics Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Novartis

2.6.1 Business Overview

2.6.2 Oncology/Cancer Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Oncology/Cancer Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Merck

2.8.1 Business Overview

2.8.2 Oncology/Cancer Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Merck Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sanofi

2.9.1 Business Overview

2.9.2 Oncology/Cancer Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Celgene

2.10.1 Business Overview

2.10.2 Oncology/Cancer Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Roche

2.11.1 Business Overview

2.11.2 Oncology/Cancer Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Novartis

2.12.1 Business Overview

2.12.2 Oncology/Cancer Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Celgene

2.13.1 Business Overview

2.13.2 Oncology/Cancer Drugs Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oncology/Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Oncology/Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Oncology/Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Oncology/Cancer Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Oncology/Cancer Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Oncology/Cancer Drugs Market Analysis by Regions

4.1 Global Oncology/Cancer Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Oncology/Cancer Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Oncology/Cancer Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

4.5 South America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

5 North America Oncology/Cancer Drugs by Countries

5.1 North America Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6 Europe Oncology/Cancer Drugs by Countries

6.1 Europe Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6.3 UK Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6.4 France Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Oncology/Cancer Drugs by Countries

7.1 Asia-Pacific Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7.5 India Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

8 South America Oncology/Cancer Drugs by Countries

8.1 South America Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Oncology/Cancer Drugs by Countries

9.1 Middle East and Africa Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

10 Global Oncology/Cancer Drugs Market Segment by Type

10.1 Global Oncology/Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Oncology/Cancer Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2013-2018)

10.2 Blood Cancer Sales Growth and Price

10.2.1 Global Blood Cancer Sales Growth (2013-2018)

10.2.2 Global Blood Cancer Price (2013-2018)

10.3 Breast Cancer Sales Growth and Price

10.3.1 Global Breast Cancer Sales Growth (2013-2018)

10.3.2 Global Breast Cancer Price (2013-2018)

10.4 Gastrointestinal Cancer Sales Growth and Price

10.4.1 Global Gastrointestinal Cancer Sales Growth (2013-2018)

10.4.2 Global Gastrointestinal Cancer Price (2013-2018)

10.5 Prostate Cancer Sales Growth and Price

10.5.1 Global Prostate Cancer Sales Growth (2013-2018)

10.5.2 Global Prostate Cancer Price (2013-2018)

10.6 Respiratory/Lung Cancer Sales Growth and Price

10.6.1 Global Respiratory/Lung Cancer Sales Growth (2013-2018)

10.6.2 Global Respiratory/Lung Cancer Price (2013-2018)

10.7 Skin Cancer Sales Growth and Price

10.7.1 Global Skin Cancer Sales Growth (2013-2018)

10.7.2 Global Skin Cancer Price (2013-2018)

10.8 Other Cancers Sales Growth and Price

10.8.1 Global Other Cancers Sales Growth (2013-2018)

10.8.2 Global Other Cancers Price (2013-2018)

11 Global Oncology/Cancer Drugs Market Segment by Application

11.1 Global Oncology/Cancer Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

11.4 Pharmacy Sales Growth (2013-2018)

12 Oncology/Cancer Drugs Market Forecast (2018-2023)

12.1 Global Oncology/Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Oncology/Cancer Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Oncology/Cancer Drugs Market Forecast (2018-2023)

12.2.2 Europe Oncology/Cancer Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Oncology/Cancer Drugs Market Forecast (2018-2023)

12.2.4 South America Oncology/Cancer Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Oncology/Cancer Drugs Market Forecast (2018-2023)

12.3 Oncology/Cancer Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Oncology/Cancer Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Oncology/Cancer Drugs Market Share Forecast by Type (2018-2023)

12.4 Oncology/Cancer Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Oncology/Cancer Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Oncology/Cancer Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Oncology/Cancer Drugs Picture

Table Product Specifications of Oncology/Cancer Drugs

Figure Global Sales Market Share of Oncology/Cancer Drugs by Types in 2017

Table Oncology/Cancer Drugs Types for Major Manufacturers

Figure Blood Cancer Picture

Figure Breast Cancer Picture

Figure Gastrointestinal Cancer Picture

Figure Prostate Cancer Picture

Figure Respiratory/Lung Cancer Picture

Figure Skin Cancer Picture

Figure Other Cancers Picture

Figure Oncology/Cancer Drugs Sales Market Share by Applications in 2017

Figure Hospital Picture

Figure Clinic Picture

Figure Pharmacy Picture

Figure United States Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Oncology/Cancer Drugs Type and Applications

Table Amgen Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Oncology/Cancer Drugs Type and Applications

Table Johnson & Johnson Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Oncology/Cancer Drugs Type and Applications

Table GlaxoSmithKline Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli lilly Basic Information, Manufacturing Base and Competitors

Table Eli lilly Oncology/Cancer Drugs Type and Applications

Table Eli lilly Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche diagnostics Basic Information, Manufacturing Base and Competitors

Table Roche diagnostics Oncology/Cancer Drugs Type and Applications

Table Roche diagnostics Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Oncology/Cancer Drugs Type and Applications

Table Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Oncology/Cancer Drugs Type and Applications

Table Pfizer Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Oncology/Cancer Drugs Type and Applications

Table Merck Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Oncology/Cancer Drugs Type and Applications

Table Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Oncology/Cancer Drugs Type and Applications

Table Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Oncology/Cancer Drugs Type and Applications

Table Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Oncology/Cancer Drugs Type and Applications

Table Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Oncology/Cancer Drugs Type and Applications

Table Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Oncology/Cancer Drugs Sales by Manufacturer (2016-2017)

Figure Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2016

Figure Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2017

Table Global Oncology/Cancer Drugs Revenue by Manufacturer (2016-2017)

Figure Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Global Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Global Oncology/Cancer Drugs Sales by Regions (2013-2018)

Table Global Oncology/Cancer Drugs Sales Market Share by Regions (2013-2018)

Table Global Oncology/Cancer Drugs Revenue by Regions (2013-2018)

Figure Global Oncology/Cancer Drugs Revenue Market Share by Regions in 2013

Figure Global Oncology/Cancer Drugs Revenue Market Share by Regions in 2017

Figure North America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Europe Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure North America Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table North America Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table North America Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure North America Oncology/Cancer Drugs Sales Market Share by Countries in 2013

Figure North America Oncology/Cancer Drugs Sales Market Share by Countries in 2017

Table North America Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Table North America Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Oncology/Cancer Drugs Revenue Market Share by Countries in 2013

Figure North America Oncology/Cancer Drugs Revenue Market Share by Countries in 2017

Figure United States Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Canada Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Europe Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Europe Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table Europe Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Table Europe Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Figure Europe Oncology/Cancer Drugs Revenue Market Share by Countries in 2016

Figure Europe Oncology/Cancer Drugs Revenue Market Share by Countries in 2017

Figure Germany Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure UK Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure France Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Russia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Italy Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Oncology/Cancer Drugs Revenue Market Share by Countries 2017

Figure China Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Japan Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Korea Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure India Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South America Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table South America Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table South America Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure South America Oncology/Cancer Drugs Sales Market Share by Countries in 2017

Table South America Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Table South America Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Oncology/Cancer Drugs Revenue Market Share by Countries in 2017

Figure Brazil Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure UAE Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Table Global Oncology/Cancer Drugs Sales by Type (2013-2018)

Table Global Oncology/Cancer Drugs Sales Share by Type (2013-2018)

Table Global Oncology/Cancer Drugs Revenue by Type (2013-2018)

Table Global Oncology/Cancer Drugs Revenue Share by Type (2013-2018)

Figure Global Blood Cancer Sales Growth (2013-2018)

Figure Global Blood Cancer Price (2013-2018)

Figure Global Breast Cancer Sales Growth (2013-2018)

Figure Global Breast Cancer Price (2013-2018)

Figure Global Gastrointestinal Cancer Sales Growth (2013-2018)

Figure Global Gastrointestinal Cancer Price (2013-2018)

Figure Global Prostate Cancer Sales Growth (2013-2018)

Figure Global Prostate Cancer Price (2013-2018)

Figure Global Respiratory/Lung Cancer Sales Growth (2013-2018)

Figure Global Respiratory/Lung Cancer Price (2013-2018)

Figure Global Skin Cancer Sales Growth (2013-2018)

Figure Global Skin Cancer Price (2013-2018)

Figure Global Other Cancers Sales Growth (2013-2018)

Figure Global Other Cancers Price (2013-2018)

Table Global Oncology/Cancer Drugs Sales by Application (2013-2018)

Table Global Oncology/Cancer Drugs Sales Share by Application (2013-2018)

Figure Global Clinic Sales Growth (2013-2018)

Figure Global Pharmacy Sales Growth (2013-2018)

Figure Global Oncology/Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Oncology/Cancer Drugs Sales Forecast by Regions (2018-2023)

Table Global Oncology/Cancer Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Figure Europe Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Figure South America Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Table Global Oncology/Cancer Drugs Sales Forecast by Type (2018-2023)

Table Global Oncology/Cancer Drugs Market Share Forecast by Type (2018-2023)

Table Global Oncology/Cancer Drugs Sales Forecast by Application (2018-2023)

Table Global Oncology/Cancer Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Amgen

Johnson & Johnson

GlaxoSmithKline

Eli lilly

Roche diagnostics

Novartis

Pfizer

Merck

Sanofi

Celgene

Roche

Novartis

Celgene

Medical oncologists specialise in cancer treatment using drugs such as chemotherapy agents.

Scope of the Report:

This report focuses on the Oncology/Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

USFDA and European Union have undertaken significant initiatives to fuel the growth of global oncology/cancer drugs market by providing pre-market approval for potential drugs under clinical development.

Asia-Pacific and LAMEA are promising regions for conducting clinical trials due a large population base and the low cost of clinical trials as compared to North America and Europe

Japan has largest share to the total Asia Pacific cancer drug market due to the high prevalence of cancer in Japanese population. Lung cancer is the major cause of death in Japanese population.

The worldwide market for Oncology/Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Amgen

Johnson & Johnson

GlaxoSmithKline

Eli lilly

Roche diagnostics

Novartis

Pfizer

Merck

Sanofi

Celgene

Roche

Novartis

Celgene

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory/Lung Cancer

Skin Cancer

Other Cancers

Market Segment by Applications, can be divided into

Hospital

Clinic

Pharmacy

There are 15 Chapters to deeply display the global Oncology/Cancer Drugs market.

Chapter 1, to describe Oncology/Cancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oncology/Cancer Drugs, with sales, revenue, and price of Oncology/Cancer Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncology/Cancer Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oncology/Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oncology/Cancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Oncology/Cancer Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Blood Cancer

1.2.2 Breast Cancer

1.2.3 Gastrointestinal Cancer

1.2.4 Prostate Cancer

1.2.5 Respiratory/Lung Cancer

1.2.6 Skin Cancer

1.2.7 Other Cancers

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.3.3 Pharmacy

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Oncology/Cancer Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Johnson & Johnson

2.2.1 Business Overview

2.2.2 Oncology/Cancer Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Johnson & Johnson Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 Oncology/Cancer Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Eli lilly

2.4.1 Business Overview

2.4.2 Oncology/Cancer Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eli lilly Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Roche diagnostics

2.5.1 Business Overview

2.5.2 Oncology/Cancer Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Roche diagnostics Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Novartis

2.6.1 Business Overview

2.6.2 Oncology/Cancer Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Oncology/Cancer Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Merck

2.8.1 Business Overview

2.8.2 Oncology/Cancer Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Merck Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sanofi

2.9.1 Business Overview

2.9.2 Oncology/Cancer Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Celgene

2.10.1 Business Overview

2.10.2 Oncology/Cancer Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Roche

2.11.1 Business Overview

2.11.2 Oncology/Cancer Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Novartis

2.12.1 Business Overview

2.12.2 Oncology/Cancer Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Celgene

2.13.1 Business Overview

2.13.2 Oncology/Cancer Drugs Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oncology/Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Oncology/Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Oncology/Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Oncology/Cancer Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Oncology/Cancer Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Oncology/Cancer Drugs Market Analysis by Regions

4.1 Global Oncology/Cancer Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Oncology/Cancer Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Oncology/Cancer Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

4.5 South America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

5 North America Oncology/Cancer Drugs by Countries

5.1 North America Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6 Europe Oncology/Cancer Drugs by Countries

6.1 Europe Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6.3 UK Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6.4 France Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Oncology/Cancer Drugs by Countries

7.1 Asia-Pacific Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7.5 India Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

8 South America Oncology/Cancer Drugs by Countries

8.1 South America Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Oncology/Cancer Drugs by Countries

9.1 Middle East and Africa Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

10 Global Oncology/Cancer Drugs Market Segment by Type

10.1 Global Oncology/Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Oncology/Cancer Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2013-2018)

10.2 Blood Cancer Sales Growth and Price

10.2.1 Global Blood Cancer Sales Growth (2013-2018)

10.2.2 Global Blood Cancer Price (2013-2018)

10.3 Breast Cancer Sales Growth and Price

10.3.1 Global Breast Cancer Sales Growth (2013-2018)

10.3.2 Global Breast Cancer Price (2013-2018)

10.4 Gastrointestinal Cancer Sales Growth and Price

10.4.1 Global Gastrointestinal Cancer Sales Growth (2013-2018)

10.4.2 Global Gastrointestinal Cancer Price (2013-2018)

10.5 Prostate Cancer Sales Growth and Price

10.5.1 Global Prostate Cancer Sales Growth (2013-2018)

10.5.2 Global Prostate Cancer Price (2013-2018)

10.6 Respiratory/Lung Cancer Sales Growth and Price

10.6.1 Global Respiratory/Lung Cancer Sales Growth (2013-2018)

10.6.2 Global Respiratory/Lung Cancer Price (2013-2018)

10.7 Skin Cancer Sales Growth and Price

10.7.1 Global Skin Cancer Sales Growth (2013-2018)

10.7.2 Global Skin Cancer Price (2013-2018)

10.8 Other Cancers Sales Growth and Price

10.8.1 Global Other Cancers Sales Growth (2013-2018)

10.8.2 Global Other Cancers Price (2013-2018)

11 Global Oncology/Cancer Drugs Market Segment by Application

11.1 Global Oncology/Cancer Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

11.4 Pharmacy Sales Growth (2013-2018)

12 Oncology/Cancer Drugs Market Forecast (2018-2023)

12.1 Global Oncology/Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Oncology/Cancer Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Oncology/Cancer Drugs Market Forecast (2018-2023)

12.2.2 Europe Oncology/Cancer Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Oncology/Cancer Drugs Market Forecast (2018-2023)

12.2.4 South America Oncology/Cancer Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Oncology/Cancer Drugs Market Forecast (2018-2023)

12.3 Oncology/Cancer Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Oncology/Cancer Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Oncology/Cancer Drugs Market Share Forecast by Type (2018-2023)

12.4 Oncology/Cancer Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Oncology/Cancer Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Oncology/Cancer Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Oncology/Cancer Drugs Picture

Table Product Specifications of Oncology/Cancer Drugs

Figure Global Sales Market Share of Oncology/Cancer Drugs by Types in 2017

Table Oncology/Cancer Drugs Types for Major Manufacturers

Figure Blood Cancer Picture

Figure Breast Cancer Picture

Figure Gastrointestinal Cancer Picture

Figure Prostate Cancer Picture

Figure Respiratory/Lung Cancer Picture

Figure Skin Cancer Picture

Figure Other Cancers Picture

Figure Oncology/Cancer Drugs Sales Market Share by Applications in 2017

Figure Hospital Picture

Figure Clinic Picture

Figure Pharmacy Picture

Figure United States Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Oncology/Cancer Drugs Type and Applications

Table Amgen Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Oncology/Cancer Drugs Type and Applications

Table Johnson & Johnson Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Oncology/Cancer Drugs Type and Applications

Table GlaxoSmithKline Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli lilly Basic Information, Manufacturing Base and Competitors

Table Eli lilly Oncology/Cancer Drugs Type and Applications

Table Eli lilly Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche diagnostics Basic Information, Manufacturing Base and Competitors

Table Roche diagnostics Oncology/Cancer Drugs Type and Applications

Table Roche diagnostics Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Oncology/Cancer Drugs Type and Applications

Table Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Oncology/Cancer Drugs Type and Applications

Table Pfizer Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Oncology/Cancer Drugs Type and Applications

Table Merck Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Oncology/Cancer Drugs Type and Applications

Table Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Oncology/Cancer Drugs Type and Applications

Table Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Oncology/Cancer Drugs Type and Applications

Table Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Oncology/Cancer Drugs Type and Applications

Table Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Oncology/Cancer Drugs Type and Applications

Table Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Oncology/Cancer Drugs Sales by Manufacturer (2016-2017)

Figure Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2016

Figure Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2017

Table Global Oncology/Cancer Drugs Revenue by Manufacturer (2016-2017)

Figure Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Global Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Global Oncology/Cancer Drugs Sales by Regions (2013-2018)

Table Global Oncology/Cancer Drugs Sales Market Share by Regions (2013-2018)

Table Global Oncology/Cancer Drugs Revenue by Regions (2013-2018)

Figure Global Oncology/Cancer Drugs Revenue Market Share by Regions in 2013

Figure Global Oncology/Cancer Drugs Revenue Market Share by Regions in 2017

Figure North America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Europe Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure North America Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table North America Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table North America Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure North America Oncology/Cancer Drugs Sales Market Share by Countries in 2013

Figure North America Oncology/Cancer Drugs Sales Market Share by Countries in 2017

Table North America Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Table North America Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Oncology/Cancer Drugs Revenue Market Share by Countries in 2013

Figure North America Oncology/Cancer Drugs Revenue Market Share by Countries in 2017

Figure United States Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Canada Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Europe Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Europe Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table Europe Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Table Europe Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Figure Europe Oncology/Cancer Drugs Revenue Market Share by Countries in 2016

Figure Europe Oncology/Cancer Drugs Revenue Market Share by Countries in 2017

Figure Germany Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure UK Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure France Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Russia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Italy Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Oncology/Cancer Drugs Revenue Market Share by Countries 2017

Figure China Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Japan Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Korea Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure India Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South America Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table South America Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table South America Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure South America Oncology/Cancer Drugs Sales Market Share by Countries in 2017

Table South America Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Table South America Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Oncology/Cancer Drugs Revenue Market Share by Countries in 2017

Figure Brazil Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Oncology/Cancer Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Oncology/Cancer Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure UAE Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)

Table Global Oncology/Cancer Drugs Sales by Type (2013-2018)

Table Global Oncology/Cancer Drugs Sales Share by Type (2013-2018)

Table Global Oncology/Cancer Drugs Revenue by Type (2013-2018)

Table Global Oncology/Cancer Drugs Revenue Share by Type (2013-2018)

Figure Global Blood Cancer Sales Growth (2013-2018)

Figure Global Blood Cancer Price (2013-2018)

Figure Global Breast Cancer Sales Growth (2013-2018)

Figure Global Breast Cancer Price (2013-2018)

Figure Global Gastrointestinal Cancer Sales Growth (2013-2018)

Figure Global Gastrointestinal Cancer Price (2013-2018)

Figure Global Prostate Cancer Sales Growth (2013-2018)

Figure Global Prostate Cancer Price (2013-2018)

Figure Global Respiratory/Lung Cancer Sales Growth (2013-2018)

Figure Global Respiratory/Lung Cancer Price (2013-2018)

Figure Global Skin Cancer Sales Growth (2013-2018)

Figure Global Skin Cancer Price (2013-2018)

Figure Global Other Cancers Sales Growth (2013-2018)

Figure Global Other Cancers Price (2013-2018)

Table Global Oncology/Cancer Drugs Sales by Application (2013-2018)

Table Global Oncology/Cancer Drugs Sales Share by Application (2013-2018)

Figure Global Clinic Sales Growth (2013-2018)

Figure Global Pharmacy Sales Growth (2013-2018)

Figure Global Oncology/Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Oncology/Cancer Drugs Sales Forecast by Regions (2018-2023)

Table Global Oncology/Cancer Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Figure Europe Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Figure South America Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Oncology/Cancer Drugs Market Forecast (2018-2023)

Table Global Oncology/Cancer Drugs Sales Forecast by Type (2018-2023)

Table Global Oncology/Cancer Drugs Market Share Forecast by Type (2018-2023)

Table Global Oncology/Cancer Drugs Sales Forecast by Application (2018-2023)

Table Global Oncology/Cancer Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Amgen

Johnson & Johnson

GlaxoSmithKline

Eli lilly

Roche diagnostics

Novartis

Pfizer

Merck

Sanofi

Celgene

Roche

Novartis

Celgene